ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1

Ai, Yilong; Liu, Shiwei; Luo, Hailing; Wu, Siyuan; Wei, Haigang; Tang, Zhe; Li, Xia; Lv, Xiaozhi*; Zou, Chen佛山科学技术学院; 佛山市第一人民医院; 南方医科大学
Journal of Immunology Research2021-8-24DOI: 10.1155/2021/6149558
24被引13阅读
引用收藏
分享

摘要

N6-Methyladenosine (m6A) modification is one of the commonest chemical modifications in eukaryotic mRNAs, which has essential effects on mRNA translation, splicing, and stability. Currently, there is a rising concern on the regulatory role of m6A in tumorigenesis. As a known component in the m6A methyltransferase complex, METTL3 (methyltransferase-like 3) plays an essential role in m6A methylation. Till now, the functions of METTL3 in oral squamous cell carcinoma (OSCC) and its relative mechanism remain to be explored. In this research, through the GEPIA database, we found that high METTL3 expression has a correlation with poor prognosis of squamous cell carcinoma of head and neck. qRT-PCR displayed that METTL3 was highly expressed in OSCC cells. Functionally, METTL3 knockdown reduced the invasion, migration, and proliferation competence of OSCC cells and attenuated the activation of CD8+ T cells. In contrast, METTL3 overexpression resulted in opposite results. GEPIA, UALCAN, and SRAMP databases, PCR, western blot, and m6A RNA methylation assay confirmed the m6A modification of PRMT5 and PD-L1 mediated by METTL3. In conclusion, our results displayed that METTL3 intensified the metastasis and proliferation of OSCC by modulating the m6A amounts of PRMT5 and PD-L1, suggesting that METTL3 may be a therapeutic target for OSCC patients.

学科与关键词

关键词
METHYLATIONMETASTASISEXPRESSIONCYCLEM(6)ARNA
相关
加载中…
  • Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells
    Li, Jinli; Momen-Heravi, Fatemeh*; Wu, Xun*; He, KailiOral Diseases, 2023, 29(5): 2012-2026.被引 8
  • METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability via m6A Modification
    Zhou, Xinying; Yang, Yang; Li, Yuejun; Liang, Guojun; Kang, Dawei; Zhou, Bing*; Li, Qingchu*Frontiers in Cell and Developmental Biology, 2022, 9: 784719.被引 12
  • METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma
    Chen, Jie; Li, Shuai; Huang, Zhexun; Cao, Congyuan; Wang, Anxun*; He, Qianting*Cancer Cell International, 2022, 22(1): 295.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Immunology Research
发表日期
2021-08-24
卷期
第 2021 卷
页码
6149558
DOI
10.1155/2021/6149558
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE

作者

  • A

    Ai, Yilong (第一作者)

    foshan univ

  • L

    Liu, Shiwei

    foshan first peoples hosp

查看全部 9 位作者收起作者
  • L

    Luo, Hailing

    foshan univ

  • W

    Wu, Siyuan

    foshan univ

  • W

    Wei, Haigang

    foshan univ

  • T

    Tang, Zhe

    foshan univ

  • L

    Li, Xia

    foshan univ

  • L

    Lv, Xiaozhi (通讯)

    southern med univ

  • Z

    Zou, Chen

    foshan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417